Sign in Subscribe
Pharmaceutical industry

Shortages and Discontinuations Report: Dextrose 5% Injection Bags

Strategic Insights

— 1 min read

The Government of the USA, through the US Food and Drug Administration, has issued a Shortages and Discontinuations Report for Dextrose 5% Injection Bags. The report highlights the current shortage situation and provides information on the available product presentations and estimated shortage duration. The shortages are attributed to a demand increase for the drug. Several manufacturers, including B. Braun Medical Inc., Baxter Healthcare, and Hospira, Inc., have provided updates on the availability of their products.

Key Takeaways:

  • The Dextrose 5% Injection Bags are currently in shortage, with a date first posted on May 19, 2014.
  • The therapeutic categories affected by the shortage include Gastroenterology, Other, and Pediatric.
  • The shortage reason, as per FDASIA, is attributed to a demand increase for the drug.
  • B. Braun Medical Inc., Baxter Healthcare, and Hospira, Inc. are among the manufacturers that have reported on the availability of their products.
  • The available product presentations include 5% 150 mL Flexible Container, 5% 250 mL ADD-Vantage Flexible Container, 5% 250 mL Flexible Container (2 port), 5% 250 mL VisIV Flexible Container, 5% 500 mL Flexible Container, 5% 500 mL Flexible Container (2 port), and 5% 1000 mL Flexible Container.
  • The shortage per manufacturer is reported as "Available" for all product presentations.
  • The company contact information is provided as 877-946-7747.
  • The presentation availability and estimated shortage duration are subject to change and should be checked with the wholesaler for available inventory.

Statistics:

  • The date first posted for the shortage was May 19, 2014.
  • The therapeutic categories affected include Gastroenterology, Other, and Pediatric.
  • The available product presentations include 10 different container sizes: 150 mL, 250 mL, 500 mL, and 1000 mL.
  • The number of manufacturers reporting on the availability of their products is 3: B. Braun Medical Inc., Baxter Healthcare, and Hospira, Inc.
  • The shortage per manufacturer is reported as "Available" for all product presentations.
  • The presentation availability and estimated shortage duration are subject to change.

Sources:

  • Washington: US Food and Drug Administration
  • B. Braun Medical Inc. (New 05/19/2014)
  • Baxter Healthcare (Reverified 04/28/2015)
  • Hospira, Inc. (Revised 05/08/2015)
  • Company Contact Information: 877-946-7747

Read more